图书简介
In this book the editors and authors provide a comprehensive overview on basic research and clinical aspects of hereditary breast and gastric tumors. In particular, this updated editorial work aims to suggest guidelines for the clinical management of patients with hereditary diffuse gastric and lobular breast cancer. Special attention is given to E-cadherin (CDH1 gene) germline mutations, genetic screening approaches, the underlying molecular mechanisms and pathological and microscopic features. In addition, the book aims to define clinical criteria for genetic screening, and highlights current surgical treatment and clinical approaches for asymptomatic mutation carriers. Other inherited predispositions involving gastric and breast carcinoma are discussed as well.Divided into eight sections, the book starts by providing an epidemiological overview of gastric and breast cancers, followed by a section dealing with new descriptions of genetic pathways in hereditary cancer predispositions. The third section focuses on pathological features of the diseases, in an effort to bridge the gap between discovery and cancer therapy development. Subsequent sections of the book are dedicated to endoscopy and breast imaging, as well as risk-reducing surgeries to curb the risk of developing cancer. The sixth section focuses on the generation of ideas for the identification of targets and novel treatment strategies. Finally, in the seventh section the authors share the story of two patients and their experiences with the diagnosis and treatment of hereditary cancer.This multidisciplinary book brings together multiple disciplines in science and technology; specifically, medicine, surgery and biology. The majority of authors are members of the International Gastric Cancer Linkage Consortium (IGCLC) and of the European Cancer Prevention Organization (EJCPO), with relevant experience in this context. Offering in-depth insights into hereditary cancers, this book represents essential reading for students, researchers, and specialists who want to extend their knowledge on hereditary gastric and breast cancers.
Part I. Epidemiology.- Family History and the Risk of Breast and Gastric Cancer.- Worldwide CDH1 Germline Mutation Frequency and the Transhormesis Hypothesis.- Hereditary Lobular Breast Cancer: A Newly Defined Syndrome.- Part II. Genetics.- Genetic Counseling and Prevention in Families at High Risk for HDGC and Other Hereditary Syndromes.- CTNNA1, a New HDGC Gene: Inactivating Mechanisms and Driven Phenotypes.- Revisiting the Biological and Clinical Impact of CDH1 Missense Variants.- Other Syndromes and Genes Associated with Gastric Cancer Predisposition.- Computer-Assisted Interpretation of Cancer-Predisposing Variants.- Part III. Pathology.- Histopathology of Hereditary Diffuse Gastric Cancer: From Grossing and 3D Microscopy to Immunophenotypic and Molecular Profiling.- HER2 Testing in Breast and Gastric Cancer with CDH1 Germline Mutations.- Pathology and Somatic Alterations in Hereditary Lobular Breast Cancers.- Part IV. Endoscopy and Imaging.- Endoscopy: Is there Anything New?.- Endoscopic Surveillance and Pathology of Biopsies in CDH1, CTNNA1 and HDGC-Like Families.- Lobular Carcinoma of the Breast: Spectrum of Imaging Findings and New Emerging Technologies on the Horizon.- Part V. Surgery.- Prophylactic Total Gastrectomy: Techniques.- Prophylactic Total Gastrectomy: How Many?.- Hereditary Lobular Breast Cancer Syndrome: Role of Surgery.- Breast Reconstruction.- Part VI. New Issues.- Psychological Burden and Preferences in CDH1 Mutation Carriers: Beyond the Cancer Diagnosis.- Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives.- The Chemoprevention of Hereditary Diffuse Gastric Cancer.- Malformations and Malformative Syndromes Associated with CDH1.- Hereditary Breast Cancer Non-CDH1 Associated.- Part VII. Patient Advocacy.- My Hereditary Gastric Cancer.- Hereditary Breast Cancer Syndrome, My Experience.- Part VIII. Miscellaneous.- β-Hemoglobinopathies and Early Onset of Cancers in Adulthood. Epidemiology in Southeastern Asia
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐